Table 4.
Entire Sample | No-MPH | MPH-Cont | MPH-Intermit | Statistic | p-value | |
---|---|---|---|---|---|---|
Dual-Energy X-ray Absorptiometry-Based Measures | ||||||
LS BMC Z-score, n=140 | 0.11±0.89 | −0.25±0.16 | 0.10±0.11 | 0.38±0.13 | F=4.61 | <0.02 |
LS aBMD Z-score, n=140 | 0.24±0.98 | −0.01±0.18 | 0.16±0.12 | 0.53±0.15 | F=3.18 | <0.05 |
Low LS aBMD Z-score, n (%), n=140¶ | 2 (1) | 1 (3) | 1 (1) | 0 | Fisher’s Exact | >0.40 |
TBLH BMC Z-score, n=54 | 0.09±0.77 | −0.27±0.23 | 0.07±0.15 | 0.34±0.17 | F=2.28 | >0.10 |
TBLH aBMD Z-score, n=54 | 0.25±0.77 | 0.06±0.23 | 0.27±0.16 | 0.33±0.18 | F=0.43 | >0.60 |
Low TBLH aBMD | 0 | 0 | 0 | 0 | --- | --- |
Z-score, n (%), n=54¶ | ||||||
Peripheral Quantitative Computed Tomography-Based Measures | ||||||
Trabecular vBMD, mg/cm3, n=150 | 201±39 | 200±7 | 201±5 | 202±6 | F=0.04 | >0.90 |
Total vBMD, mg/cm3, n=150 | 322±54 | 322±10 | 320±6 | 326±8 | F=0.18 | >0.80 |
Strength Index, mg2/mm4, n=150 | 22.9±11.1 | 26.4±2.0 | 23.0±1.3 | 20.6±1.6 | F=2.49 | <0.09 |
Cortical vBMD, mg/cm3, n=35 | 1060±31 | 1064±13 | 1058±8 | 1062±9 | F=0.11 | >0.80 |
Cortical Thickness, mm, n=35 | 2.3±0.4 | 2.6±0.2 | 2.1±0.1 | 2.2±0.1 | F=3.17 | <0.06 |
Endosteal Circumference, mm, n=35 | 17.4±3.9 | 18.4±1.6 | 16.9±1.0 | 17.4±1.1 | F=0.31 | >0.70 |
Periosteal Circumference, mm, n=35 | 31.5±5.1 | 34.8±2.1 | 30.4±1.2 | 31.4±1.5 | F=1.65 | >0.20 |
Polar Section Modulus, mm3, n=35 | 142±70 | 192±28 | 128.7±16 | 137±19 | F=2.02 | >0.10 |
MPH: psychostimulants, LS: lumbar spine, BMC: bone mineral content, aBMD: areal bone mineral density, TBLH: total body less head, vBMD: volumetric bone mineral density.
Age-sex-height-race-specific Z-scores for LS and TBLH BMC and aBMD were generated following the Bone Mineral Density in Childhood Study [30].
Defined as a Z-score ≤ −2.0.
Significant results (p<0.05) are bolded and marginally significant results (p<0.10) are bolded and italicized.